Gautschi, Oliver; Zangemeister-Wittke, U.; Stahel, R. A. (2003). Comment on “A pilot trial of G3139, a bcl-2 antisense oligonucleotide, and paclitaxel in patients with chemorefractory small-cell lung cancer”, by C. M. Rudin et al. (Ann Oncol 2002; 13: 539–545). Annals of oncology, 14(1), p. 170. Oxford University Press 10.1093/annonc/mdg001
|
Text
mdg001.pdf - Published Version Available under License Publisher holds Copyright. Download (31kB) | Preview |
Item Type: |
Journal Article (Further Contribution) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Medical Oncology |
UniBE Contributor: |
Gautschi, Oliver |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
0923-7534 |
Publisher: |
Oxford University Press |
Language: |
English |
Submitter: |
Markus Müller |
Date Deposited: |
27 Sep 2018 12:26 |
Last Modified: |
05 Dec 2022 15:13 |
Publisher DOI: |
10.1093/annonc/mdg001 |
BORIS DOI: |
10.7892/boris.116047 |
URI: |
https://boris.unibe.ch/id/eprint/116047 |
Actions (login required)
 |
Edit item |